JFL Life Sciences (NSE:JFLLIFE) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:JFLLIFE JFL Life Sciences Ltd NSE:JFLLIFE
72 GF Score
Price ₹10.60
GF Value ₹35.89
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is JFL Life Sciences Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

JFL Life Sciences Valuation Rank Related Terms

NSE:JFLLIFE
72GF Score
JFL Life Sciences Ltd NSE:JFLLIFE
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is JFL Life Sciences (NSE:JFLLIFE) Overvalued in 2026?

Based on GuruFocus' analysis, JFL Life Sciences stock appears to be undervalued. The current stock price of ₹10.60 is trading 70.5% below its estimated GF Value™ of ₹35.89. GuruFocus considers JFL Life Sciences to be Significantly Undervalued.

Key valuation signals for NSE:JFLLIFE:

  • Valuation Rank:
  • GF Value™: ₹35.89 vs. price of ₹10.60 (70.5% below fair value)
  • GF Score™: 72/100 with 2 warning signs

No single metric tells the full story. See the NSE:JFLLIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

JFL Life Sciences Business Description

Address Jodhpur Cross Road, 309, Satyam Mall, Opposite Saman Complex, Near Vishweshwar Mahadev Mandir, Settelite, Ahmedabad, GJ, IND, 380015
JFL Life Sciences Ltd is engaged in the business of manufacturing pharmaceutical products. The company's product portfolio consists of Dry powder injections (B-Lactam), Tablets and Capsules (B-Lactam) solid oral dosage forms, and general tablets and capsules. Its operating segment comprises of manufacturing and selling of pharmaceutical products. Geographically, the company sells its products both in India and outside India.
72GF Score

Get the complete analysis for NSE:JFLLIFE

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹10.60
Price
₹35.89
GF Value